An additional mutation in the p53 gene, R273H, is associated with several types of hematopoietic cancers, including AML, chronic myelogenous leukemia (CML), and myelodysplastic syndrome (MDS) [105]. This evidence concerns the gene TP53 and hematopoietic and lymphoid cell neoplasm.